🏛️ Verified NIH Record • Updated 2025-08-12
Therapeutic Plasma Exchange in Septic Shock: A Pilot Study (NCT05093075)
🟢 Recruiting Phase2 📋 Clinical Research Protocol Sponsor: University of Manitoba
🩺 Plain-English Summary (8th-Grade Level)
The investigators propose to conduct a multi-center randomized pilot feasibility trial comparing therapeutic plasma exchange to standard of care in patients diagnosed with septic shock.
Who can join: Review the eligibility criteria below.
Location: Foothills Medical Centre — Calgary, Alberta
Age range: 16 Years
🧪 Interventions in This Study
- Therapeutic Plasma Exchange (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Foothills Medical Centre — Calgary, Alberta
- Southern Health Campus — Calgary, Alberta
- University of Alberta — Edmonton, Alberta
- University of Manitoba — Winnipeg, Manitoba
- Hamilton Health Sciences - Juravinski — Hamilton, Ontario
- St. Joseph's Hospital — Hamilton, Ontario
- Queen's University at Kingston — Kingston, Ontario
- Ottawa Hospital — Ottawa, Ontario
- St. Michael's Hospital — Toronto, Ontario
- Centre Hospitalier de L'Université de Montréal (Chum), — Montreal, Quebec
- Universite Laval — Québec, Quebec
📞 Contact the Study Coordinator
Phone: (204) 787-2128
Email: erimmer@cancercare.mb.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Septic Shock
- Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study — Birmingham, Alabama
- Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance — Cleveland, Ohio
- Blood Purification for the Treatment of Pathogen Associated Shock — Washington D.C., District of Columbia
- Venous Excess Ultrasound for Personalized Resuscitation in Septic Shock — London, Ontario
- Evaluating Dynamic Arterial Elastance in Septic Shock Patients. — Bogotá,
- Randomized Control Study in REsuscitation of SEpsis Trial — Bogotá, Bogota D.C.
Explore by condition: All Septic Shock clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.